Article
Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.
Antimicrobial agents and chemotherapy - 1 Nov 1996
Tankovic J, Perichon B, Duval J, Courvalin P
Abstract excerpt
We have analyzed by gene amplification and sequencing mutations in the quinolone resistance-determining regions of the gyrA, gyrB, and parC genes of fluoroquinolone-resistant Streptococcus pneumoniae mutants obtained during therapy or in vitro. Mutations leading to substitutions in ParC were detected in the two mutants obtained in vivo, BM4203-R (substitution of a histidine for an aspartate at position 84...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
